Imiquimod 5% cream, an immune response modifier licensed for treatment of external ano-genital warts and superficial basal cell carcinomata, is known to cause local erythema, oedema and, rarely, exacerbation of psoriasis. We describe a case of exacerbation of eczema following application of this cream in a man with penile warts.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564744 | PMC |
| http://dx.doi.org/10.1136/sti.2005.018226 | DOI Listing |
Publication Analysis
Top Keywords
imiquimod cream
8
case severe
4
severe eczema
4
eczema imiquimod
4
cream imiquimod
4
cream immune
4
immune response
4
response modifier
4
modifier licensed
4
licensed treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!